Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients

Cancer Treatment Reviews

Volumn 10, Issue SUPPL. 1, 1983, Pages 93-101

  Scheulen, Max E ^a   Niederle, Norbert ^a   Bremer, Karl ^a   Schütte, Jochen ^a   Seeber, Siegfried ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IFOSFAMIDE; MESNA; NEW DRUG;

BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CELL PROTECTION; CLINICAL ARTICLE; DRUG RESISTANCE; HUMAN; LEUKEMIA; LYMPHOMA; PREVENTION; SOLID TUMOR; THERAPY; URINARY TRACT;

CYCLOPHOSPHAMIDE; DRUG EVALUATION; DRUG INTERACTIONS; FEMALE; HUMANS; IFOSFAMIDE; MALE; MERCAPTOETHANOL; MESNA; NEOPLASMS; TESTICULAR NEOPLASMS; URINARY TRACT;

EID: 0021028584     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(83)80013-9     Document Type: Article

References (20)

1. Chemotherapeutische Behandlungsmöglichkeiten bei fortgeschrittenen Sarkomen
2. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors
3. Clinical trial of isophosphamide (NSC-109724)—Results and side effects
4. Pharmacological studies with ifosfamide—a new oxazaphosphorine compound
5. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds
6. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide
7. Prophylaktische Alkalisierung des Harns bei zytostatischer Tumorbehandlung mit den Oxazaphosphorin-Derivaten Cyclophosphamid und Ifosfamid
8. Ifosfamide in the treatment of recurrent or disseminated lung cancer
9. Rationale for the use of alternating non-cross-resistant chemotherapy
10. Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas
11. Pronounced antiemetic activity of the antipsychotic drug levomepromazine in patients receiving cancer chemotherapy
12. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat
13. Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment
14. Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: Preliminary results
15. Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy
16. Isophosphamide in refractory metastasized tumors: a clinical phase II study
17. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammine-platinum (II) in disseminated nonseminomatous testicular cancer
18. Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus
19. Evaluation of a cooperative clinical study on the cytostatic agent ifosfamide
20. Kombinierte Chemotherapie des metastasierenden Melanoblastoms mit Ifosfamid und cis-Diamino-dichloro-platin (II)